Skip to main content
Top
Published in: BMC Cardiovascular Disorders 1/2019

Open Access 01-12-2019 | Stroke | Case report

Can men with atrial fibrillation really rest easy with a CHA2DS2-VASc score of 0?

Authors: Chen-Di Cheng, Xiang Gu, Hong-Xiao Li, Ruo-Yu Duan, Lei Sun, Yi Zhang, Zheng-Yu Bao, Jian-Hua Shen, Fu-Kun Chen, Ye Zhu

Published in: BMC Cardiovascular Disorders | Issue 1/2019

Login to get access

Abstract

Background

Atrial fibrillation (AF) significantly increases the risk of ischemic stroke depending on various risk factors. The CHA2DS2-VASc score is used widely to improve stratification of AF-related stroke to identify for whom anticoagulation could be safely withheld. As upstream therapy, the management of lifestyle for AF and related stroke prevention has been ongoing for past decades.

Case presentation

A 56-year-old male was taken to our hospital because of acute ischemic stroke. Without intracranial vascular malformation and angiostenosis, two small emboli were successfully taken out from the left middle cerebral artery by mechanical thrombectomy. During the hospitalisation, no apparent abnormalities were found in various laboratory tests, echocardiogram or the coronary computed tomography angiography. However, asymptomatic paroxysmal AF was first diagnosed and was presumed to be responsible for his stroke. Noticeable, he was always in good fitness benefiting from the formed good habits of no smoking and drinking. With a CHA2DS2-VASc score of 0, he had no history of any known diseases or risk factors associated with AF and related stroke. Instead of lacking exercise, he persisted in playing table tennis faithfully 3–4 times a week and 2–3 h each time over the past 30 years, and, in fact, has won several amateur table tennis championships.

Conclusion

In view of the possible pathophysiological mechanisms resulting from the long-term vigorous endurance exercise, it may be a potential risk factor for developing AF and even for subsequent stroke. Not merely should strengthen the screening for AF in specific individuals as sports enthusiasts, but the necessity of oral anticoagulant for those with a CHA2DS2-VASc score of 0 might deserve the further investigation.
Appendix
Available only for authorised users
Literature
1.
go back to reference Lip GY, Tse HF, Lane DA. Atrial fibrillation. Lancet. 2012;379(9816):648–61.CrossRef Lip GY, Tse HF, Lane DA. Atrial fibrillation. Lancet. 2012;379(9816):648–61.CrossRef
2.
go back to reference Vigdis V, Carla T, Steven E, et al. Association between atrial fibrillation, anticoagulation, risk of cerebrovascular events and multimorbidity in general practice: a registry-based study. BMC Cardiovasc Disord. 2016;16(1):61.CrossRef Vigdis V, Carla T, Steven E, et al. Association between atrial fibrillation, anticoagulation, risk of cerebrovascular events and multimorbidity in general practice: a registry-based study. BMC Cardiovasc Disord. 2016;16(1):61.CrossRef
3.
go back to reference Kirchhof P, Dipak K, Casadei B, et al. 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS: the Task Force for the management of atrial fibrillation of the European Society of Cardiology (ESC). Eur Heart J. 2016;37(38):2853.CrossRef Kirchhof P, Dipak K, Casadei B, et al. 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS: the Task Force for the management of atrial fibrillation of the European Society of Cardiology (ESC). Eur Heart J. 2016;37(38):2853.CrossRef
4.
go back to reference Schnabel RB, Yin X, Gona P, et al. 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham heart study: a cohort study. Lancet. 2015;386(9989):154–62.CrossRef Schnabel RB, Yin X, Gona P, et al. 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham heart study: a cohort study. Lancet. 2015;386(9989):154–62.CrossRef
5.
go back to reference Mohanty S, Mohanty P, Tamaki M, et al. Differential Association of Exercise Intensity with Risk of atrial fibrillation in men and women: evidence from a meta-analysis. J Cardiovasc Electrophysiol. 2016;27(9):1021–9.CrossRef Mohanty S, Mohanty P, Tamaki M, et al. Differential Association of Exercise Intensity with Risk of atrial fibrillation in men and women: evidence from a meta-analysis. J Cardiovasc Electrophysiol. 2016;27(9):1021–9.CrossRef
6.
go back to reference Baldesberger S, Bauersfeld U, Candinas R, et al. Sinus node disease and arrhythmias in the long-term follow-up of former professional cyclists. Eur Heart J. 2007;29(1):71–8.CrossRef Baldesberger S, Bauersfeld U, Candinas R, et al. Sinus node disease and arrhythmias in the long-term follow-up of former professional cyclists. Eur Heart J. 2007;29(1):71–8.CrossRef
7.
go back to reference Sanchis-Gomar F, Perez-Quilis C, Lippi G, et al. Atrial fibrillation in highly trained endurance athletes — description of a syndrome. Int J Cardiol. 2017;226:11–20.CrossRef Sanchis-Gomar F, Perez-Quilis C, Lippi G, et al. Atrial fibrillation in highly trained endurance athletes — description of a syndrome. Int J Cardiol. 2017;226:11–20.CrossRef
8.
go back to reference D'Ascenzi F, Cameli M, Ciccone MM, et al. The controversial relationship between exercise and atrial fibrillation: clinical studies and pathophysiological mechanisms. J Cardiovasc Med. 2015;16(12):802–10.CrossRef D'Ascenzi F, Cameli M, Ciccone MM, et al. The controversial relationship between exercise and atrial fibrillation: clinical studies and pathophysiological mechanisms. J Cardiovasc Med. 2015;16(12):802–10.CrossRef
9.
go back to reference Mont L, Elosua R, Brugada J, et al. Endurance sport practice as a risk factor for atrial fibrillation and atrial flutter. Europace. 2008;11(1):11–7.CrossRef Mont L, Elosua R, Brugada J, et al. Endurance sport practice as a risk factor for atrial fibrillation and atrial flutter. Europace. 2008;11(1):11–7.CrossRef
10.
go back to reference Morseth B, Graffiversen S, Jacobsen BK, et al. Physical activity, resting heart rate, and atrial fibrillation: the Tromso study. Eur Heart J. 2016;37(29):2307–13.CrossRef Morseth B, Graffiversen S, Jacobsen BK, et al. Physical activity, resting heart rate, and atrial fibrillation: the Tromso study. Eur Heart J. 2016;37(29):2307–13.CrossRef
11.
go back to reference Preventive Services Task Force US. Screening for atrial fibrillation with electrocardiography US Preventive Services Task Force recommendation statement. JAMA. 2018;320(5):478–84.CrossRef Preventive Services Task Force US. Screening for atrial fibrillation with electrocardiography US Preventive Services Task Force recommendation statement. JAMA. 2018;320(5):478–84.CrossRef
12.
go back to reference Healey JS, Connolly SJ, Gold MR, et al. Subclinical atrial fibrillation and the risk of stroke. N Engl J Med. 2012;366(5):120–9.CrossRef Healey JS, Connolly SJ, Gold MR, et al. Subclinical atrial fibrillation and the risk of stroke. N Engl J Med. 2012;366(5):120–9.CrossRef
13.
go back to reference January CT, Wann LS, Alpert JS, et al. ACC/AHA Task Force members. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation. 2014;130:2071–104.CrossRef January CT, Wann LS, Alpert JS, et al. ACC/AHA Task Force members. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation. 2014;130:2071–104.CrossRef
14.
go back to reference Lip GY, Skjøth F, Rasmussen LH, et al. Oral anticoagulation, aspirin, or no therapy in patients with nonvalvular AF with 0 or 1 stroke risk factor based on the CHA2DS2-VASc score. J Am Coll Cardiol. 2015;65(14):1385–94.CrossRef Lip GY, Skjøth F, Rasmussen LH, et al. Oral anticoagulation, aspirin, or no therapy in patients with nonvalvular AF with 0 or 1 stroke risk factor based on the CHA2DS2-VASc score. J Am Coll Cardiol. 2015;65(14):1385–94.CrossRef
15.
go back to reference Fauchier L, Clementy N, Bisson A, et al. Should atrial fibrillation patients with only 1 nongender-related CHA2DS2-VASc risk factor be anticoagulated? Stroke. 2016;47(7):1831.CrossRef Fauchier L, Clementy N, Bisson A, et al. Should atrial fibrillation patients with only 1 nongender-related CHA2DS2-VASc risk factor be anticoagulated? Stroke. 2016;47(7):1831.CrossRef
16.
go back to reference JCS Joint Working Group. Guidelines for pharmacotherapy of atrial fibrillation (JCS 2013). Circ J. 2014;78(8):1997–2021.CrossRef JCS Joint Working Group. Guidelines for pharmacotherapy of atrial fibrillation (JCS 2013). Circ J. 2014;78(8):1997–2021.CrossRef
17.
go back to reference Myrstad M, Aarønæs M, Graff-Iversen S, et al. Physical activity, symptoms, medication and subjective health among veteran endurance athletes with atrial fibrillation. Clin Res Cardiol. 2016;105(2):154–61.CrossRef Myrstad M, Aarønæs M, Graff-Iversen S, et al. Physical activity, symptoms, medication and subjective health among veteran endurance athletes with atrial fibrillation. Clin Res Cardiol. 2016;105(2):154–61.CrossRef
18.
go back to reference Proietti M, Boriani G, Laroche C, et al. Self-reported physical activity and major adverse events in patients with atrial fibrillation: a report from the EURObservational research Programme pilot survey on atrial fibrillation (EORP-AF) general registry. Europace. 2017;19:535–43.CrossRef Proietti M, Boriani G, Laroche C, et al. Self-reported physical activity and major adverse events in patients with atrial fibrillation: a report from the EURObservational research Programme pilot survey on atrial fibrillation (EORP-AF) general registry. Europace. 2017;19:535–43.CrossRef
19.
go back to reference Daccarett M, Badger TJ, Akoum N, et al. Association of left atrial fibrosis detected by delayed-enhancement magnetic resonance imaging and the risk of stroke in patients with atrial fibrillation. J Am Coll Cardiol. 2011;57(7):831–8.CrossRef Daccarett M, Badger TJ, Akoum N, et al. Association of left atrial fibrosis detected by delayed-enhancement magnetic resonance imaging and the risk of stroke in patients with atrial fibrillation. J Am Coll Cardiol. 2011;57(7):831–8.CrossRef
20.
go back to reference Guasch E, Benito B, Qi X, et al. Atrial fibrillation promotion by endurance exercise: demonstration and mechanistic exploration in an animal model. J Am Coll Cardiol. 2013;62(1):68–77.CrossRef Guasch E, Benito B, Qi X, et al. Atrial fibrillation promotion by endurance exercise: demonstration and mechanistic exploration in an animal model. J Am Coll Cardiol. 2013;62(1):68–77.CrossRef
21.
go back to reference Savino JA, Halperin JL. Should patients with atrial fibrillation and 1 stroke risk factor (CHA2DS2-VASc score 1 in men, 2 in women) be anticoagulated? The CHA2DS2-VASc 1 conundrum: decision making at the lower end of the risk spectrum. Circulation. 2016;133:1504–11.CrossRef Savino JA, Halperin JL. Should patients with atrial fibrillation and 1 stroke risk factor (CHA2DS2-VASc score 1 in men, 2 in women) be anticoagulated? The CHA2DS2-VASc 1 conundrum: decision making at the lower end of the risk spectrum. Circulation. 2016;133:1504–11.CrossRef
22.
go back to reference Szymanski FM, Lip GY, Filipiak KJ, et al. Stroke risk factors beyond the CHA2DS2-VASc score: can we improve our identification of “high stroke risk” patients with atrial fibrillation? Am J Cariol. 2015;116:1781–18.CrossRef Szymanski FM, Lip GY, Filipiak KJ, et al. Stroke risk factors beyond the CHA2DS2-VASc score: can we improve our identification of “high stroke risk” patients with atrial fibrillation? Am J Cariol. 2015;116:1781–18.CrossRef
23.
go back to reference Di Biase L, Santangeli P, Anselmino M, et al. Does the left atrial appendage morphology correlate with the risk of stroke in patients with atrial fibrillation? Results from a multicenter study. J Am Coll Cardiol. 2012;60:531–8.CrossRef Di Biase L, Santangeli P, Anselmino M, et al. Does the left atrial appendage morphology correlate with the risk of stroke in patients with atrial fibrillation? Results from a multicenter study. J Am Coll Cardiol. 2012;60:531–8.CrossRef
Metadata
Title
Can men with atrial fibrillation really rest easy with a CHA2DS2-VASc score of 0?
Authors
Chen-Di Cheng
Xiang Gu
Hong-Xiao Li
Ruo-Yu Duan
Lei Sun
Yi Zhang
Zheng-Yu Bao
Jian-Hua Shen
Fu-Kun Chen
Ye Zhu
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Cardiovascular Disorders / Issue 1/2019
Electronic ISSN: 1471-2261
DOI
https://doi.org/10.1186/s12872-019-1150-z

Other articles of this Issue 1/2019

BMC Cardiovascular Disorders 1/2019 Go to the issue